Concepedia

Tetsuya Kurosu

TK

Statistics

Publications

21

Citations

960

H-Index

18

Active since

2003

Affiliations

Tokyo Medical and Dental University(Current)

Toranomon Hospital

Tetsuya Kurosu is an author at Tokyo Medical and Dental University specializing in life sciences, molecular oncology, and apoptosis.

Publications per year

2003–2015

21

Publications

21

BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells

Tetsuya Kurosu, Tetsuya Fukuda, Tohru Miki et al. · Oncogene · 2003 · 120 citations

, , +13

Reactive oxygen species generated by hematopoietic cytokines play roles in activation of receptor-mediated signaling and in cell cycle progression

Mitsuko Iiyama, Kazuhiko Kakihana, Tetsuya Kurosu et al. · Cellular Signalling · 2005 · 93 citations

, , +16

The two major imatinib resistance mutations E255K and T315I enhance the activity of BCR/ABL fusion kinase

Masahide Yamamoto, Tetsuya Kurosu, Kazuhiko Kakihana et al. · Biochemical and Biophysical Research Communications · 2004 · 67 citations

, , +8

FLT3-ITD confers resistance to the PI3K/Akt pathway inhibitors by protecting the mTOR/4EBP1/Mcl-1 pathway through STAT5 activation in acute myeloid leukemia

Ayako Nogami, Gaku Oshikawa, Keigo Okada et al. · Oncotarget · 2015 · 64 citations · Full text

, , +16

Glycogen synthase kinase-3β and p38 phosphorylate cyclin D2 on Thr280 to trigger its ubiquitin/proteasome-dependent degradation in hematopoietic cells

A. Kida, Kazuhiko Kakihana, Shunsuke Kotani et al. · Oncogene · 2007 · 56 citations

, , +13

1–5 of 21